Skip to content

Efficacy of Asafoetida and Ferula Herbal Syrup on Blood Glucose Control

Evaluation of the Efficacy of Asafoetida and Ferula Herbal Syrup on Blood Glucose Control and Metabolic Parameters in Patients with Type 2 Diabetes: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250722066592N1
Enrollment
80
Registered
2025-07-30
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: The intervention group will receive 10 cc of an oral herbal syrup containing mountain almond, chovil, and wild rose, administered three times a day at 8-hour intervals for a duration o

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Informed consent; Age between 18 and 70 years; Definitive diagnosis of type 2 diabetes based on physician diagnosis; Hemoglobin A1C less than 8.5; At least 6 months have passed since diagnosis of type 2 diabetes;Participants who were using oral hypoglycemic drugs, insulin, or diet control at the time of the study and their treatment regimen had been stable for at least 3 months.

Exclusion criteria

Exclusion criteria: Patients at high risk for hypoglycemia Immunodeficiency Pregnancy and lactation Uncontrolled blood pressure Liver and kidney failure Uncontrolled thyroid disease Concomitant use of any drug that inhibits or induces moderate to strong hepatic isoenzymes and P-glycoprotein History of use of antipsychotics, psychotropic drugs, or alcohol and anticoagulant drugs Concomitant use of two antiplatelet drugs Patients with a diagnosis of neurological diseases or psychiatric disorders

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar. Timepoint: Beginning of the study, end of the sixth and twelfth weeks. Method of measurement: Blood test.;HbA1C. Timepoint: Beginning of the study, end of the sixth and twelfth weeks. Method of measurement: Blood test.;Blood sugar after a meal. Timepoint: Beginning of the study, end of the sixth and twelfth weeks. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Marjan Moghadamnia

Kermanshah University of Medical Sciences

Majmaj1372@yahoo.com+98 83 3427 6489

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026